Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagogues.

about

Update on the treatment of type 2 diabetes mellitus Comparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic review

P2860

Q28073342-12547D36-CE9F-4915-B12D-E5968E72CC95 Q28540671-3732B11B-9AA0-4710-B73A-20AA7412176E

P2860

Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagogues.

Item

http://www.wikidata.org/entity/Q38071018

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagogues.

@en

type

Item

label

Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagogues.

@en

prefLabel

Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagogues.

@en

P1476

Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagogues.

@en

P2093

Itamar Raz

http://www.w3.org/2001/XMLSchema#string

Roy Eldor

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

Secondary failure of metformin monotherapy in clinical practice.

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study

P304

85-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DMRR.2358

http://www.w3.org/2001/XMLSchema#string

P478

28 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234041283

http://www.w3.org/2001/XMLSchema#string

P698

23280872

http://www.w3.org/2001/XMLSchema#string

Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagogues.

about

P2860

P2860

Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagogues.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698